Filtered By:
Specialty: Nursing
Management: National Institute for Health and Clinical Excelle

This page shows you your search results in order of date.

Order by Relevance | Date

Total 4 results found since Jan 2013.

NICE approves new oral anti-coagulant for atrial fibrillation
The drug edoxaban has been given the official seal of approval for NHS use in preventing stroke and blood clots in patients with a common heart disorder.
Source: Nursing Times Breaking News - September 24, 2015 Category: Nursing Source Type: news

NICE advises against aspirin for cutting stroke risk in AF patients
The National Institute for Health and Care Excellence has recommended that people with atrial fibrillation are prescribed an anticoagulant instead of aspirin to reduce their risk of stroke.
Source: Nursing Times Breaking News - June 20, 2014 Category: Nursing Source Type: news

Statins and cardiovascular disease.
Authors: Abstract Essential facts Heart disease, stroke and peripheral arterial disease, known collectively as cardiovascular disease (CVD), cause one in three of all deaths in the UK. High levels of low-density lipoprotein (LDL) cholesterol can lead to hardening of the arteries, a risk factor for CVD. Statins are a group of drugs that act on the liver to lower LDL cholesterol rates in the blood. As many as seven million people in the UK currently take statins, at a cost of £285 million a year, according to the National Institute for Health and Care Excellence (NICE). PMID: 24641035 [PubMed - in process]
Source: Nursing Standard - March 19, 2014 Category: Nursing Tags: Nurs Stand Source Type: research

NICE backs drug to reduce stroke risk for AF patients
The National Institute for Clinical Excellence is now recommending the use of apixaban for some patients with irregular heartbeats to help prevent them experiencing stroke or systemic embolism.
Source: Nursing Times Breaking News - January 23, 2013 Category: Nursing Source Type: news